Raleigh Capital Management Inc. Grows Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Raleigh Capital Management Inc. lifted its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 272.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41 shares of the medical instruments supplier’s stock after purchasing an additional 30 shares during the quarter. Raleigh Capital Management Inc.’s holdings in Mettler-Toledo International were worth $61,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Jade Capital Advisors LLC purchased a new position in Mettler-Toledo International in the third quarter worth about $1,500,000. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after buying an additional 18 shares during the last quarter. Crew Capital Management Ltd. increased its position in shares of Mettler-Toledo International by 13.0% during the third quarter. Crew Capital Management Ltd. now owns 755 shares of the medical instruments supplier’s stock valued at $1,132,000 after acquiring an additional 87 shares in the last quarter. Suncoast Equity Management raised its holdings in Mettler-Toledo International by 2.0% in the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after acquiring an additional 9 shares during the last quarter. Finally, Penn Davis Mcfarland Inc. bought a new position in Mettler-Toledo International in the 3rd quarter valued at approximately $4,853,000. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 2.3 %

Shares of NYSE MTD opened at $1,320.35 on Thursday. Mettler-Toledo International Inc. has a 12-month low of $928.49 and a 12-month high of $1,546.93. The firm has a market capitalization of $28.20 billion, a price-to-earnings ratio of 37.03, a price-to-earnings-growth ratio of 4.24 and a beta of 1.14. The firm has a 50 day moving average of $1,421.35 and a 200 day moving average of $1,394.57.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, topping the consensus estimate of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The firm had revenue of $946.75 million during the quarter, compared to analyst estimates of $929.13 million. During the same period in the prior year, the business posted $10.19 EPS. Mettler-Toledo International’s revenue was down 3.6% on a year-over-year basis. Sell-side analysts predict that Mettler-Toledo International Inc. will post 40.35 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on MTD. Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price target for the company. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research note on Monday, August 5th. JPMorgan Chase & Co. lifted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. The Goldman Sachs Group increased their price objective on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a “neutral” rating in a research report on Tuesday, July 9th. Finally, StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $1,363.75.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.